Capital Advisors, Ltd. LLC Spectrum Pharmaceuticals Inc Transaction History

Capital Advisors, Ltd. LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 05, 2022	SELL	$0.7 - $1.4 $74 - $148	-106 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$0.63 - $1.59 $66 - $168	106 New	106 $0

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Capital Advisors, Ltd. LLC, based on Form 13F filings with the SEC.

Stay updated on Capital Advisors, Ltd. LLC with notifications on news.